Agomelatine, an innovative pharmacological response to unmet needs

@article{Strat2008AgomelatineAI,
  title={Agomelatine, an innovative pharmacological response to unmet needs},
  author={Y. Le Strat and P. Gorwood},
  journal={Journal of Psychopharmacology},
  year={2008},
  volume={22},
  pages={4 - 8}
}
Abstract Most of the available antidepressants, with different pharmacological profiles, such as inhibitors of serotonin reuptake (SSRIs) or norepinephrine reuptake (NRIs) or both (SNRIs), have limitations leading some patients to drop out of treatment. Another direction of research has therefore been undertaken, based initially on the fact that affective disorders are most often characterized by abnormal patterns of circadian rhythms. This consideration has led to the synthesis of agomelatine… Expand
10 Citations
Agomelatine: The Novel Antidepressant
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine.
  • 69
Delirium: a disturbance of circadian integrity?
  • 60
Agomelatine in the treatment of mood and anxiety disorders.
  • 4
Pharmacological Treatments for Disordered Gambling: A Meta-analysis
  • 10
  • PDF

References

SHOWING 1-10 OF 56 REFERENCES
Antidepressant action of agomelatine (S 20098) in a transgenic mouse model
  • 98
Addressing circadian rhythm disturbances in depressed patients
  • 15
  • PDF
Major depressive disorder, sleep EEG and agomelatine: an open-label study.
  • 149
  • PDF
...
1
2
3
4
5
...